Page 3 - Randomized Study News Today

/PRNewswire/ -- A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper...

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker findings from the companys...

Elderberry's health benefits include immune support, high nutritional value & heart health. Read to learn more about elderberry benefits 2023

Elderberry's health benefits include immune support, high nutritional value & heart health. Read to learn more about elderberry benefits 2023

When dealing with hypothyroidism, some important diet changes should be made. Here are the list of foods on a hypothyroidism diet 2023.

- Plenary Scientific Session to highlight Incyte-discovered novel anti-mutant CALR-targeted monoclonal antibody INCA033989 - Data from three of the Company's LIMBER studies evaluating ruxolitinib

Program details on keynote addresses, distinguished awards and late-breaking abstracts are being provided by program planners of the American Society for Radiation Oncology (ASTRO) Annual Meeting, set for October 23-26, in San Antonio, TX.

Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia

-- Full data support the potential of obicetrapib to address unmet medical need for millions of patients who cannot achieve their LDL-C targets with high-intensity statin therapy (HIS) alone -- -- Treatment

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least